| Continued decline in blood collection and transfusion in the U nited S tates–2015 KD Ellingson, MRP Sapiano, KA Haass, AA Savinkina, ML Baker, ... Transfusion 57, 1588-1598, 2017 | 329 | 2017 |
| Slowing decline in blood collection and transfusion in the United States–2017 JM Jones, MRP Sapiano, AA Savinkina, KA Haass, ML Baker, RA Henry, ... Transfusion 60, S1-S9, 2020 | 144 | 2020 |
| A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose BP Linas, A Savinkina, C Barbosa, PP Mueller, M Cerdá, K Keyes, ... Journal of Substance Abuse Treatment 120, 108158, 2021 | 110 | 2021 |
| Transfusion-transmitted infections reported to the national healthcare safety network hemovigilance module KA Haass, MRP Sapiano, A Savinkina, MJ Kuehnert, SV Basavaraju Transfusion medicine reviews 33 (2), 84-91, 2019 | 88 | 2019 |
| Supplemental findings from the national blood collection and utilization surveys, 2013 and 2015 MRP Sapiano, AA Savinkina, KD Ellingson, KA Haass, ML Baker, ... Transfusion 57 (Suppl 2), 1599, 2017 | 84 | 2017 |
| Projected estimates of opioid mortality after community-level interventions BP Linas, A Savinkina, R Madushani, J Wang, GE Yazdi, A Chatterjee, ... JAMA network open 4 (2), e2037259-e2037259, 2021 | 62 | 2021 |
| Long-term infective endocarditis mortality associated with injection opioid use in the United States: a modeling study JA Barocas, G Eftekhari Yazdi, A Savinkina, S Nolen, C Savitzky, ... Clinical Infectious Diseases 73 (11), e3661-e3669, 2021 | 56 | 2021 |
| Population-level health effects of involuntary displacement of people experiencing unsheltered homelessness who inject drugs in US cities JA Barocas, SK Nall, S Axelrath, C Pladsen, A Boyer, AH Kral, ... Jama 329 (17), 1478-1486, 2023 | 51 | 2023 |
| Supplemental findings of the 2017 national blood collection and utilization survey MRP Sapiano, JM Jones, AA Savinkina, KA Haass, JJ Berger, ... Transfusion 60, S17-S37, 2020 | 51 | 2020 |
| Transfusion‐associated adverse events and implementation of blood safety measures‐findings from the 2017 National Blood Collection and Utilization Survey AA Savinkina, KA Haass, MRP Sapiano, RA Henry, JJ Berger, ... Transfusion 60, S10-S16, 2020 | 49 | 2020 |
| Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a … A Savinkina, A Bilinski, M Fitzpatrick, AD Paltiel, Z Rizvi, J Salomon, ... BMJ open 12 (9), e061752, 2022 | 40 | 2022 |
| Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients AL Pappy, A Savinkina, C Bicknese, S Neill, NM Oyesiku, ... Pituitary 22, 520-531, 2019 | 39 | 2019 |
| Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study JA Barocas, A Savinkina, J Adams, R Jawa, ZM Weinstein, JH Samet, ... The Lancet Public Health 7 (1), e56-e64, 2022 | 38 | 2022 |
| Cost projections for implementation of safety interventions to prevent transfusion‐transmitted Zika virus infection in the United States KD Ellingson, MRP Sapiano, KA Haass, AA Savinkina, ML Baker, ... Transfusion 57, 1625-1633, 2017 | 31 | 2017 |
| Projected long-term impact of the coronavirus disease 2019 (COVID-19) pandemic on hepatitis C outcomes in the United States: a modeling study JA Barocas, A Savinkina, S Lodi, RL Epstein, TC Bouton, H Sperring, ... Clinical infectious diseases 75 (1), e1112-e1119, 2022 | 25 | 2022 |
| Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion‐related adverse reactions in the United States C Edens, KA Haass, M Cumming, A Osinski, L O'Hearn, K Passanisi, ... Transfusion 59 (2), 524-533, 2019 | 24 | 2019 |
| Estimated costs and outcomes associated with use and nonuse of medications for opioid use disorder during incarceration and at release in Massachusetts A Chatterjee, M Weitz, A Savinkina, A Macmadu, R Madushani, RA Potee, ... JAMA Network Open 6 (4), e237036-e237036, 2023 | 16 | 2023 |
| Population-level strategies for nirmatrelvir/ritonavir prescribing—a cost-effectiveness analysis A Savinkina, AD Paltiel, JS Ross, G Gonsalves Open Forum Infectious Diseases 9 (12), ofac637, 2022 | 15 | 2022 |
| Estimated clinical outcomes and cost-effectiveness associated with provision of addiction treatment in US primary care clinics R Jawa, Y Tin, S Nall, SL Calcaterra, A Savinkina, LR Marks, SD Kimmel, ... JAMA Network Open 6 (4), e237888-e237888, 2023 | 14 | 2023 |
| Simulated cost-effectiveness and long-term clinical outcomes of addiction care and antibiotic therapy strategies for patients with injection drug use–associated infective … JW Adams, A Savinkina, JC Hudspeth, MJ Gai, R Jawa, LR Marks, ... JAMA Network Open 5 (2), e220541-e220541, 2022 | 11 | 2022 |
Benjamin P LinasBoston Universitybmc.org의 이메일 확인됨
